Form 4: Director Cathleen Bairey Merz Acquires iRhythm Shares
Statement of Changes in Beneficial Ownership
Director Cathleen Bairey Merz acquired 1,573 restricted stock units in iRhythm Holdings, Inc. as part of an equity grant.
Summary
- Director Cathleen Bairey Merz was granted 1,573 restricted stock units (RSUs) on May 27, 2026.
- Each RSU represents a contingent right to receive one share of iRhythm Holdings, Inc. (IRTC) common stock.
- Following this transaction, the director's total beneficial ownership stands at 10,546 shares.
- The RSUs vest on the earlier of one year from the grant date or the date of the next annual meeting.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation with no impact on the company's operational or financial trajectory.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
Negatives
- None identified in this filing.
Risks
- Standard market risks associated with equity ownership in a publicly traded company.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a standard disclosure of director equity compensation.
Industry Context
StockSavvy.ai notes that this filing is a routine disclosure of director compensation following the company's recent holding company reorganization, which is standard practice for maintaining board alignment in the medical technology sector.
Comparison to Industry Standards
- The grant of RSUs to directors is a standard corporate governance practice among mid-cap medical technology companies to ensure long-term incentive alignment.
- The vesting schedule (earlier of one year or next annual meeting) is consistent with typical director compensation structures in the U.S. healthcare industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Holding Company Reorganization | iRhythm Holdings, Inc. became the successor issuer to iRhythm Technologies, Inc. on January 12, 2026. | 01/12/2026 | Administrative change with no change to proportionate interests of security holders. |
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity grant to a director.
Next Steps
- Vesting of the 1,573 RSUs on the earlier of May 27, 2027, or the date of the next annual meeting.
Key Dates
| Date | Description |
|---|---|
| 05/27/2026 | Date of the RSU grant transaction. |
| 05/29/2026 | Date the Form 4 was filed with the SEC. |
Keywords
iRhythm Holdings, IRTC, Form 4, Insider Transaction, Director Equity, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.